Abstract
Glycogen synthase kinase-3 (GSK-3) is a kind of serine-threonine protein kinase. It places important roles in several signaling pathways and it is a key therapeutic target for a number of diseases, such as diabetes, cancer, Alzheimer’s disease and chronic inflammation. Mg2+ ions which interact with ATP are conserved in GSK. They are important in phosphoryl transfer. Li+ is an inhibitor for GSK-3. It is used to treat bipolar mood disorder. This paper illustrates the effect of Li+ on GSK-3. When Mg 2+I is replaced by Li+, the atom fluctuation of GSK-3 will rise, and the in-line phosphoryl transfer mechanism is probably demolished and the binding of pre-phosphorylated substrates may be disturbed. All the results we obtained clearly suggest that inhibition to GSK-3 is caused by the Mg 2+I replacement with Li+.
Similar content being viewed by others
References
Embi N, Rylatt DB, Cohen P (1980) Eur J Biochem 107:519–527
Cross DA, Alessi DR, Cohen P, Andelkovich M, Hemmings BA (1995) Nature 378:785–789
Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR (2000) Nature 406:86–90
Woodgett JR (1990) EMBO J 9:2431–2438
Zhang N, Jiang YJ, Zou JW, Zhuang SL, Jin HX, Yu QS (2007) Proteins 67:941–949
Zhang N, Jiang YJ, Zou JW, Zhang B, Wang YH, Yu QS (2006) Eur J Med Chem 41:373–378
Martinez A, Castro A, Medina M (2006) Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors. Wiley, Hoboken, New Jersey
Jope RS, Johnson GV (2004) Trends Biochem Sci 29:95–102
Fiol CJ, Wang A, Roeske RW, Roach PJ (1990) J Biol Chem 265:6061–6065
Herberg FW, Doyle ML, Cox S, Taylor SS (1999) Biochemistry 38:6352–6360
Cade JFJ (1949) Med J Aust 2:349–352
Klein PS, Melton DA (1996) Proc Natl Acad Sci USA 93:8455–8459
Stambolic V, Ruel L, Woodgett JR (1996) Curr Biol 6:1664–1668
Davies SP, Reddy H, Caivano M, Cohen P (2000) Biochem J 351:95–105
Ryves WJ, Harwood AJ (2001) Biochem Biophys Res Commun 280:720–725
Ryves WJ, Dajani R, Pearl L, Harwood AJ (2002) Biochem Biophys Res Commun 290:967–972
Jin HX, Wu TX, Jiang YJ, Zou JW, Zhuang SL, Mao X, Yu QS (2007) J Mol Struc (THEOCHEM) 805:9–15
Aimes RT, Hemmer W, Taylor SS (2000) Biochem 39:8325–8332
Grant B, Hemmer W, Tsigelny I, Adams JA, Taylor SS (1998) Biochem 37:7708–7715
Bártová I, Otyepka M, Křĭž Z, Koča J (2005) Protein Sci 14:445–451
Bártová I, Otyepka M, Křĺž Z, Koča J (2004) Protein Sci 13:1449–1457
ter Haar E, Coll JT, Austen DA, Hsiao HM, Swenson L, Jain J (2001) Nat Struct Biol 8:593–596
Dajani R, Fraser E, Roe SM, Young N, Good V, Dale TC, Pearl LH (2001) Cell 105:721–732
Dajani R, Fraser E, Roe SM, Yeo M, Good VM, Thompson V, Dale TC, Pearl LH (2003) EMBO J 22:494–501
Frame S, Cohen P, Biondi RM (2001) Mol Cell 7:1321–1327
Acknowledgments
This work was supported by grants from National High Technology Research and Development Program of China (863 Program, 2007AA02Z301), Natural Science Foundation of China (No.20803063).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sun, H., Jiang, Yj., Yu, Qs. et al. The effect of Li+ on GSK-3 inhibition: Molecular dynamics simulation. J Mol Model 17, 377–381 (2011). https://doi.org/10.1007/s00894-010-0738-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00894-010-0738-0